about
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner.Osteoporosis and the jaws: questions remain to be answered.Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis.
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Rationale for the use of clodronate in osteoporosis.
@en
type
label
Rationale for the use of clodronate in osteoporosis.
@en
prefLabel
Rationale for the use of clodronate in osteoporosis.
@en
P2093
P356
P1476
Rationale for the use of clodronate in osteoporosis.
@en
P2093
Beneton MN
McCloskey EV
P2888
P356
10.1007/BF01623223
P407
P478
P577
1993-01-01T00:00:00Z
P6179
1008648437